Nova Patents
ATE320808T1

Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy

Abstract

The present invention covers radiosensitizers containing as an active ingredient halogenated derivatives of boronated porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron-capture therapy and photodynamic therapy. The present invention also covers methods for using these radiosensitizers in tumor imaging and cancer treatment.

Term

Term ended

Projected expiry passed 5 June 2022, 4.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

32 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
87420301United States of AmericaA
11701002United States of AmericaA

Members32

Family members, oldest first
DocumentOfficeKind
CA2449316A1CanadaA1
WO02098417A1World Intellectual Property Organization (WIPO)A1
US2003032799A1United States of AmericaA1
US2003083494A1United States of AmericaA1
US6566517B2United States of AmericaB2
US2003165426A1United States of AmericaA1
GB0400163D0United KingdomD0
GB2393123AUnited KingdomA
EP1404319A1European Patent Office (EPO)A1
KR20040032108ARepublic of KoreaA
US6759403B2United States of AmericaB2
ZA200400056BSouth AfricaB
GB2393123BUnited KingdomB
JP2005504012AJapanA
EP1404319A4European Patent Office (EPO)A4
CN1620289AChinaA
RU2003138076ARussian FederationA
US6951640B2United States of AmericaB2
HK1078472A1Hong Kong, ChinaA1
EP1404319B1European Patent Office (EPO)B1
AT320808TAustriaT
ATE320808T1This recordAustriaT1
DE60210074D1GermanyD1
AU2002310314B2AustraliaB2
DK1404319T3DenmarkT3
ES2257554T3SpainT3
PT1404319EPortugalE
CN1279907CChinaC
DE60210074T2GermanyT2
RU2310447C2Russian FederationC2
JP4247110B2JapanB2
KR100899752B1Republic of KoreaB1